Feeling Positive St. John's Wort 300 mg
Product analysis
Feeling Positive St. John's Wort 300 mg is aimed at mood support, with findings that depend on the extract and the setting. It can interact with many medicines, so check compatibility with a pharmacist before using it.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The extract identifies hypericin, helping clarify its preparation. Its ingredient quality cannot be compared confidently from the available information.
Ingredient Transparency100
The amount and form are clearly stated. That makes the extract easier to compare with another clearly described preparation.
Value For Money40
Value for money remains uncertain. The available cost-and-content information does not support a reliable comparison with other extracts.
Customer Satisfaction74
Customer ratings are positive across a moderate review base. That provides a useful but limited picture of satisfaction.
Product Focus67
Mood findings depend on the preparation and largely come from clinical settings. The serving is below the daily amounts used in many trials and does not establish an equivalent daily regimen.
- Format
Capsule - Container
- 150 Capsule(s)
- Per serving
- $0.13
- Customer rating
- 4.6 · 466 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
St. John's Wort extract (Hypericin) | 300 mg |
How this ingredient is rated
Composition and Label Disclosure
Composition and Label Disclosure50
Explicit Label Detail
Commercial Price and Usability
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- St John's wort for major depression.
- Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
- A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
- Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
- Complementary therapies for clinical depression: an overview of systematic reviews.